These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 1009703)

  • 21. Polychemotherapeutic treatment of patients with metastatic breast cancer.
    Balázs M; Tüske M
    Acta Med Hung; 1986; 43(4):407-11. PubMed ID: 3601586
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hybrid chemotherapy consisting of cyclophosphamide, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, and vinblastine (C-MOPP/ABV) as first-line treatment for patients with advanced Hodgkin disease.
    Montoto S; Camós M; López-Guillermo A; Bosch F; Cervantes F; Blandé J; Esteve J; Cobo F; Nomdedeu B; Campo E; Montserrat E
    Cancer; 2000 May; 88(9):2142-8. PubMed ID: 10813727
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [VP-16, vincristine, adriamycin and cyclophosphamide (EVAC) in patients with small-cell lung cancer].
    Abad-Esteve A; Rosell R; Moreno I; Fernández-Marcial C; Roselló M; Ribas Mundó M
    Med Clin (Barc); 1988 Apr; 90(14):569-72. PubMed ID: 2840536
    [No Abstract]   [Full Text] [Related]  

  • 24. Doxorubicin, dacarbazine, vincristine, and cyclophosphamide in the treatment of advanced gastrointestinal leiomyosarcoma.
    Choi TK; Ng A; Wong J
    Cancer Treat Rep; 1985 Apr; 69(4):443-4. PubMed ID: 3995513
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cytostatic therapy of bronchial carcinoma].
    Dold U
    Dtsch Med Wochenschr; 1972 Apr; 97(15):618-9. PubMed ID: 4112729
    [No Abstract]   [Full Text] [Related]  

  • 26. [The use of lithium carbonate in mastectomized patients undergoing cancer therapy].
    Marzetti L; Marcellini G; Midulla C
    Clin Ter; 1982 Nov; 103(4):405-9. PubMed ID: 6817959
    [No Abstract]   [Full Text] [Related]  

  • 27. [Lithium carbonate--a preventive agent against leukopenia during cytostatic therapy].
    Lahousen M; Pickel H; Haas J
    Wien Klin Wochenschr; 1984 Oct; 96(19):739-41. PubMed ID: 6441351
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Encouraging results with cytostatic therapy in metastasizing breast cancer (author's transl)].
    Michlmayr G; Kratzer H; Denz H; Huber H
    Wien Klin Wochenschr; 1981 Mar; 93(6):205-7. PubMed ID: 7281697
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Combined cytostatic treatment of solid tumours with cyclophosphamide (Endoxan), vincristine, methylaminopterin (Methotrexate) and 5-fluorouracil].
    Brincker H
    Ugeskr Laeger; 1971 May; 133(19):926-9. PubMed ID: 5559763
    [No Abstract]   [Full Text] [Related]  

  • 30. Combination of modalities in soft tissue sarcomas.
    Karakousis CP
    Int Adv Surg Oncol; 1982; 5():91-113. PubMed ID: 6896509
    [No Abstract]   [Full Text] [Related]  

  • 31. [Cytostatic therapy: neurologic and psychiatric syndromes].
    Strian F; Maurach R
    Med Klin; 1980 Jun; 75(13):478-84. PubMed ID: 6997713
    [No Abstract]   [Full Text] [Related]  

  • 32. Results of a prospective clinical trial comparing two cytotoxic regimes containing adriamycin in women with advanced breast cancer.
    Priestman TJ
    Clin Oncol; 1975 Sep; 1(3):207-11. PubMed ID: 1212828
    [No Abstract]   [Full Text] [Related]  

  • 33. [Combined drug/hormone therapy in metastatic breast cancer with vincristine, adriamycin, cyclophosphamide and high dose medroxyprogesterone acetate--VAC-MAP. Preliminary results of a phase II study of the German Cancer Society's Internal Medicine Oncology Task Force].
    Wander HE; Nagel GA; Blossey HC; Kordilla F; Stamm S; Matthressen W; Weiss J
    Onkologie; 1982 Aug; 5 Suppl():8-12. PubMed ID: 6752794
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combination chemotherapy for disseminated carcinoma of the breast.
    Lozada JA; Grillo-López A; Vélez-Garciá E
    Bol Asoc Med P R; 1975 Jun; 67(6):157-63. PubMed ID: 1055588
    [No Abstract]   [Full Text] [Related]  

  • 35. Reversal of cyclophosphamide induced neutropenia by hypertransfusion and androgen therapy.
    DiBenedetto J; Higby DJ; Chester SJ; Albala MM
    J Med; 1980; 11(5-6):385-92. PubMed ID: 6962825
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunochemotherapy with rituximab and cyclophosphamide, doxorubicin, vincristine, and prednisone significantly improves response and time to treatment failure, but not long-term outcome in patients with previously untreated mantle cell lymphoma: results of a prospective randomized trial of the German Low Grade Lymphoma Study Group (GLSG).
    Lenz G; Dreyling M; Hoster E; Wörmann B; Dührsen U; Metzner B; Eimermacher H; Neubauer A; Wandt H; Steinhauer H; Martin S; Heidemann E; Aldaoud A; Parwaresch R; Hasford J; Unterhalt M; Hiddemann W
    J Clin Oncol; 2005 Mar; 23(9):1984-92. PubMed ID: 15668467
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phase I clinical study of a static magnetic field combined with anti-neoplastic chemotherapy in the treatment of human malignancy: initial safety and toxicity data.
    Salvatore JR; Harrington J; Kummet T
    Bioelectromagnetics; 2003 Oct; 24(7):524-7. PubMed ID: 12955758
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Therapeutic results of patients with osteogenic sarcoma by the protocol COSS 77 (author's transl)].
    Prindull G; Poppe H; Jentsch E; Schauer A
    Unfallheilkunde; 1981 Dec; 84(12):524-5. PubMed ID: 6948465
    [No Abstract]   [Full Text] [Related]  

  • 39. [Chemotherapy associated with surgical treatment in primary bronchial cancers].
    Karrer K
    Bronches; 1974; 24(2):56-69. PubMed ID: 4422178
    [No Abstract]   [Full Text] [Related]  

  • 40. Failure of scalp hypothermia to prevent hair loss when cyclophosphamide is added to doxorubicin and vincristine.
    Middleton J; Franks D; Buchanan RB; Hall V; Smallwood J; Williams CJ
    Cancer Treat Rep; 1985 Apr; 69(4):373-5. PubMed ID: 3995509
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.